A number of firms have modified their ratings and price targets on shares of Zimmer Biomet (NYSE: ZBH) recently:8/10/2026 – Zimmer Biomet had its price target raised by Canaccord Genuity Group Inc. from $83.00 to $100.00. 8/6/2026 – Zimmer Biomet had its price target raised by Sanford C. Bernstein from $91.00 to $93.00. 8/6/2026 – Zimmer Biomet had its price target raised by Royal Bank Of Canada from $101.00 to $110.00. Zimmer Biomet (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. See AlsoReceive News & Ratings for Zimmer Biomet Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.